Clinical Trial Update: Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating vincristine, doxorubicin, dexamethasone, and ixazomib in relapsed/refractory ALL, relapsed/refractory lymphoblastic lymphoma, or mixed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Phenotype Acute Leukemia
• Or Refractory Acute Lymphoblastic Leukemia
• Or Refractory Lymphoblastic Lymphoma

Drugs mentioned

• vincristine, doxorubicin, dexamethasone, ixazomib

Snippet

Sponsor: Ehab L Atallah | Conditions: Relapsed or Refractory Acute Lymphoblastic Leukemia, Relapsed or Refractory Lymphoblastic Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2020-01-22